MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)

Conditions:   Cytomegalovirus Infection;   Cytomegalovirus Disease Interventions:   Drug: Letermovir tablet;   Drug: Letermovir IV Sponsor:   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials